single-dr.php

JDR Vol.7 No.3 pp. 303-312
(2012)
doi: 10.20965/jdr.2012.p0303

Paper:

Streptococcus suis: An Emerging Biothreat

Tsutomu Sekizaki

Research Center for Food Safety and OIE Collaborating Centre for Food Safety, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan

Received:
September 20, 2011
Accepted:
November 8, 2011
Published:
April 1, 2012
Keywords:
Streptococcus suis, toxic shock syndrome, zoonosis, meningitis, endocarditis
Abstract

Streptococcus suis infections in pigs are often seen in major hog-producing countries. This bacterium is also a zoonotic agent affecting, for the most part, people in close contact with swine or pork by-products. The human S. suis infections have generally been sporadic; however, in recent years, this bacterium has strongly emerged as an important public health issue in Southeast and East Asia. Most human infections have so far been recognized to cause adult meningitis; however, a recent outbreak that occurred in Sichuan Province, China, involved a fatal disease, known as the streptococcus toxic-shock syndrome. Almost all human infections were caused by contact with diseased pigs or contaminated pork by-products, so reducing the number of virulent strains of S. suis in hog populations is an important task in diminishing the level of risk in human S. suis infections. However, the S. suis strains show various degrees of virulence, and many clinically healthy pigs may carry S. suis, some of which are avirulent and some of whichmust be virulent. Therefore, a rapid assay system to identify the virulent strains of S. suis is urgently needed. Here, general information on S. suis is described, and the recent research progress on this bacterium is summarized.

Cite this article as:
Tsutomu Sekizaki, “Streptococcus suis: An Emerging Biothreat,” J. Disaster Res., Vol.7, No.3, pp. 303-312, 2012.
Data files:
References
  1. [1] R. Higgins and M. Gottschalk, “Streptococcocal Diseases,” In Diseases of swine, B. E. Straw, J. J. Zimmerman, S. D’Allaire, D. J. Taylor (Ed.), Ames, Iowa, Blackwell Publishing Professional, pp. 769-783, 2006.
  2. [2] M. Gottschalk, M. Segura, and J. Xu, “Streptococcus suis infections in humans: the Chinese experience and the situation in North America,” Animal Health Research Reviews, Vol.8, pp. 29-45, 2007.
  3. [3] H. Yu, H. Jing, Z. Chen, H, Zheng, X. Zhu, H. Wang, S. Wang, L. Liu, R. Zu, L. Luo, N. Xiang, H. Liu, X. Liu, Y. Shu, S. S. Lee, S. K. Chuang, Y.Wang, J. Xu,W. Yang, and the Streptococcus suis study groups, “Human Streptococcus suis Outbreak, Sichuan, China,” Emerging Infectious Diseases, Vol.12, pp. 914-920, 2006.
  4. [4] B. Perch, K. B. Pedersen, and J. Henrichsen, “Serology of capsulated streptococci pathogenic for pigs: six new serotypes of Streptococcus suis,” Journal of Clinical Microbiology, Vol.17, pp. 993-996, 1983.
  5. [5] M. Gottschalk, R. Higgins, M. Jacques, K. R. Mittal, and J. Henrichsen, “Description of 14 new capsular types of Streptococcus suis,” J. of Clinical Microbiology, Vol.27, pp. 2633-2636, 1989.
  6. [6] M. Gottschalk, R. Higgins, M. Jacques, M. Beaudoin, and J. Henrichsen, “Characterization of six new capsular types (23 through 28) of Streptococcus suis,” J. of Clinical Microbiology, Vol.29, pp. 2590-2594, 1991.
  7. [7] R. Higgins, M. Gottschalk, M. Boudreau, A. Lebrun, and J. Henrichsen, “Description of six new capsular types (29-34) of Streptococcus suis,” J. of Veterinary Diagnostic Investigation, Vol.7, pp. 405-406, 1995.
  8. [8] J. E. Hill, M. Gottschalk, R. Brousseau, J. Harel, S. M. Hemmingsen, and S. H. Goh, “Biochemical analysis, cpn60 and 16S rDNA sequence data indicate that Streptococcus suis serotypes 32 and 34, isolated from pigs, are Streptococcus orisratti,” Veterinary Microbiology, Vol.107, pp. 63-69, 2005.
  9. [9] F. A. Clifton-Hadley, “Streptococcus suis type 2 infections,” British Veterinary Journal, Vol.139, pp. 1-5, 1983.
  10. [10] R. Higgins and M. Gottschalk, “Distribution of Streptococcus suis, capsular types in 1995,” Canadian Veterinary Journal, Vol.37, p. 242, 1996.
  11. [11] R. Higgins, M. Gottschalk, M. Beaudoin, and S. A. Rawluk, “Distribution of Streptococcus suis capsular types in Quebec and western Canada,” Canadian Veterinary Journal, Vol.33, pp. 27-30, 1992.
  12. [12] C. E. de Moor, “Septicaemic infections in pigs, caused by haemolytic streptococci of new Lancefield groups designated R, S, and T,” Antonie van Leeuwenhoek Journal of Microbiology and Serology, Vol.29, pp. 272-280, 1963.
  13. [13] S. D. Elliott, “Streptococcal infection in young pigs. I. An immunochemical study of the causative agent (PM streptococcus),” J. of Hygiene, Vol.64, pp. 205-212, 1966.
  14. [14] R. S. Windsor and S. D. Elliot, “Streptococcal infection in young pigs. IV. An outbreak of streptococcal meningitis in weaned pigs,” J. of Hygiene, Vol.75, pp. 69-78, 1975.
  15. [15] R. Kilpper-Bälz and K. H. Schleifer, “Streptococcus suis sp. nov., nom. rev.,” Int. J. of Systematic Bacteriology, Vol.37, pp. 160-162, 1987.
  16. [16] F.M. Aarestrup, S. E. Jorsal, and N. E. Jensen, “Serological characterization and antimicrobial susceptibility of Streptococcus suis isolates from diagnostic samples in Denmark during 1995 and 1996,” Veterinary Microbiology, Vol.60, pp. 59-66, 1998.
  17. [17] H. D. Nghia, N. T. Hoa, D. Linh le, J. Campbell, T. S. Diep, N. V. Chau, N. T. Mai, T. T. Hien, B. Spratt, J. Farrar, and C. Schultsz, “Human case of Streptococcus suis serotype 16 infection,” Emerging Infectious Diseases, Vol.14, pp. 155-157, 2008.
  18. [18] D. Takamatsu, K. Wongsawan, M. Osaki, H. Nishino, T. Ishiji, P. Tharavichitkul, B. Khantawa, A. Fongcom, S. Takai, and T. Sekizaki, “Streptococcus suis in humans, Thailand,” Emerging Infectious Diseases, Vol.14, pp. 181-183, 2008.
  19. [19] A. Kerdsin, S. Dejsirilert, P. Sawanpanyalert, A. Boonnark, W. Noithachang, D. Sriyakum, S. Simkum, S. Chokngam, M. Gottschalk, Y. Akeda, and K. Oishi, “Sepsis and spontaneous bacterial peritonitis in Thailand,” Lancet, Vol.378, p. 960, 2011.
  20. [20] H. Smith, V. Veenbergen, J. Van der Velde, M. Damman, H. J. Wisselink, and M. A. Smits, “The cps genes of Steptococcus suis serotypes 1, 2, and 9: Development of rapid serotype-specific PCR assays,” J. of Clinical Microbiology, Vol.37, pp. 3146-3152, 1999.
  21. [21] H. J. Wisselink, J. J. Joosten, and H. E. Smith, “Multiplex PCR assays for simultaneous detection of six major serotypes and two virulence-associated phenotypes of Streptococcus suis in tonsillar specimens from pigs,” Journal of Clinical Microbiology, Vol.40, pp. 2922-2929, 2002.
  22. [22] O. Okwumabua, M. O’Connor, and E. Shull, “A polymerase chain reaction (PCR) assay specific for Streptococcus suis based on the gene encoding the glutamate dehydrogenase,” FEMS Microbiology Letters, Vol.218, pp. 79-84, 2003.
  23. [23] M. C. Heidt, W. Mohamed, T. Hain, P. R. Vogt, T. Chakraborty, and E. Domann, “Human infective endocarditis caused by Streptococcus suis serotype 2,” J. of Clinical Microbiology, Vol.43, pp. 4898-4901, 2005.
  24. [24] Y. Kataoka, T. Yoshida, and T. Sawada, “A 10-year survey of antimicrobial susceptibility of Streptococcus suis isolates from swine in Japan,” J. of Veterinary Medical Sciences, Vol.62, pp. 1053-1057, 2000.
  25. [25] J. Marie, H. Morvan, F. Berthelot-Hérault, P. Sanders, I. Kempf, A. V. Gautier-Bouchardon, E. Jouy, and M. Kobisch, “Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000,” J. of Antimicrobial Chemotherapy, Vol.50, pp. 201-209, 2002
  26. [26] H. J. Wisselink, K. T. Veldman, C. Van den Eede, S. A. Salmon, and D. J. Mevius, “Quantitative susceptibility of Streptococcus suis strains isolated from diseased pigs in seven European countries to antimicrobial agents licensed in veterinary medicine,” Veterinary Microbiology, Vol.113, pp. 73-82, 2006.
  27. [27] Y.W. Chu, T. K. Cheung, M. Y. Chu, V. Y. Tsang, J. T. Fung, K. M. Kam, and J. Y. Lo, “Resistance to tetracycline, erythromycin and clindamycin in Streptococcus suis serotype 2 in Hong Kong,” Int. J. of Antimicrobial Agents, Vol.34, pp. 181-182, 2009.
  28. [28] N. T. Hoa, T. T. Chieu, H. D. Nghia, N. T. Mai, P. H. Anh, M. Wolbers, S. Baker, J. I. Campbell, N. V. Chau, T. T. Hien, J. Farrar, and C. Schultsz, “The antimicrobial resistance patterns and associated determinants in Streptococcus suis isolated from humans in southern Vietnam, 1997-2008,” BMC Infectious Diseases, Vol.11, p. 6, 2011.
  29. [29] H. I. Field, D. Buntain, and J. T. Done, “Studies on piglet mortality I. – Streptococcal Meningitis and Arthritis,” Veterinary Records, Vol.66, pp. 454-455, 1954.
  30. [30] K. S. Willenburg, D. E. Sentochnik, and R. N. Zadoks, “Human Strptococcus suis meningitis in the United States,” New England J. of Medicine, Vol.354, p. 1325, 2006.
  31. [31] A. Manzin, C. Palmieri, C. Serra, B. Saddi, M. S. Princivalli, G. Loi, G. Angioni, F. Tiddia, P. E. Varaldo, and B. Facinelli, “Streptococcus suis Meningitis without History of Animal Contact, Italy,” Emerging Infectious Diseases, Vol.14, pp. 1946-1948, 2008.
  32. [32] Y. Feng, H. Zhang, Y. Ma, and G. F. Gao, “Uncovering newly emerging variants of Streptococcus suis, an important zoonotic agent,” Trends in Microbiology, Vol.18, pp. 124-131, 2009.
  33. [33] H. F. L.Wertheim, H. D. Nghia, W. Taylor, and C. Schultsz, “Streptococcus suis: an emerging human pathogen,” Clinical Infectious Diseases, Vol.48, pp. 617-625, 2009.
  34. [34] J. P. Arends and H. C. Zanen, “Meningitis caused by Streptococcus suis in humans,” Reviews of Infectious Diseases, Vol.10, pp. 131-137, 1988.
  35. [35] M. S. Bergdoll, B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis, “A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates,” Lancet, Vol.1(8228), pp. 1017-1021, 1981.
  36. [36] M. L. Cohen and S. Falkow, “Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome,” Science, Vol.211, pp. 842-844, 1981.
  37. [37] L. A. Cone, D. R. Woodard, P. M. Schlievert, and G. S. Tomory, “Clinical and bacteriologic observations of a toxic shocklike syndrome due to Streptococcus pyogenes,” New England J. of Medicine, Vol.317, pp. 146-149, 1987.
  38. [38] J.M. Musser, A. R. Hauser, M. H. Kim, P.M. Schlievert, K. Nelson, and R. K. Selander, “Streptococcus pyogenes causing toxicshock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression,” Proc. of the National Academy of Sciences U S A, Vol.88, pp. 2668-2672, 1991.
  39. [39] S. Hashikawa, Y. Iinuma, M. Furushita, T. Ohkura, T. Nada, K. Torii, T. Hasegawa, and M. Ohta, “Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome,” J. of Clinical Microbiology, Vol,42, pp. 186-192, 2004.
  40. [40] N. T. Mai, N. T. Hoa, T. V. Nga, D. Linh le, T. T. Chau, D. X. Sinh, N. H. Phu, L. V. Chuong, T. S. Diep, J. Campbell, H. D. Nghia, T. N. Minh, N. V. Chau, M. D. de Jong, N. T. Chinh, T. T. Hien, J. Farrar, and C. Schultsz, “Streptococcus suis Meningitis in Adults in Vietnam,” Clinical Infectious Diseases, Vol.46, pp. 659-667, 2008.
  41. [41] C. Suankratay, P. Intalapaporn, P. Nunthapisud, K. Arunyingmongkol, and H. Wilde, “Streptococcus suis meningitis in Thailand,” Southeast Asian J. of Tropical Medicine and Public Health, Vol.35, pp. 868-876, 2004.
  42. [42] P.-Y. Cheung, K. L. Lo, T. T. Cheung, W. H. Yeung, P. H. Leung, and K. M. Kam, “Streptococcus suis in retail markets: How prevalent is it in raw pork?,” Int. J. of Food Microbiology, Vol.127, pp. 316-320, 2008.
  43. [43] B. Chang, A. Wada, T. Ikebe, M. Ohnishi, K. Mita, M. Endo, H. Matuo, Y. Asatuma, S. Kuramoto, H. Sekiguchi, M. Yamazaki, H. Yoshikawa, N. Watabe, H. Yamada, S. Kurita, Y. Imai, and H. Watanabe, “Charecteristics of Streptococcus suis isolated from patients in Japan,” Japanese J. of Infectious Diseases, Vol.59, pp. 397-399, 2006.
  44. [44] A. A. C. Jacobs, P. L. W. Loeffen, A. J. G. van den Berg and P. K. Storm, “Identification, purification, and characterization of a thiolactivated hemolysin (suilysin) of Streptococcus suis,” Infection and Immunity, Vol.62, pp. 1742-1748, 1994.
  45. [45] U. Vecht, H. J. Wisselink, M. L. Jellema and H. E. Smith, “Identification of two proteins associated with virulence of Streptococcus suis type 2,” Infection and Immunity, Vol.59, pp. 3156-3162, 1991.
  46. [46] U. Vecht, H. J. Wisselink, J. E. van Dijk and H. E. Smith, “Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype,” Infection and Immunity, Vol.60, pp. 550-556, 1992.
  47. [47] M. Gottschalk, A. Lebrun, H. Wisselink, J. D. Dubreuil, H. Smith and U. Vecht, “Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2,” Canadian J. of Veterinary Research, Vol.62, pp. 75-79, 1998.
  48. [48] H. E. Smith, U. Vecht, H. J.Wisselink, N. Stockhofe-Zurwieden, Y. Biermann, and M. A. Smits, “Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs,” Infection and Immunity, Vol.64, pp. 4409-4412, 1996.
  49. [49] C. G. Baums, U. Kaim, M. Fulde, G. Ramachandran, R. Goethe, and P. Valentin-Weigand, “Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis,” Infection and Immunity, Vol.74, pp. 6154-6162, 2006.
  50. [50] D. Takamatsu, M. Osaki, P. Tharavichitkul, S. Takai, and T. Sekizaki, “Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population,” J. of Medical Microbiology, Vol.57, pp. 488-494, 2008.
  51. [51] A. de Greeff, H. Buys, R. Verhaar, J. Dijkstra, L. van Alphen, and H. E. Smith, “Contribution of fibronectin binding protein to pathogenesis of Streptococcus suis serotype 2,” Infection and Immunity, Vol.70, pp. 319-1325, 2002.
  52. [52] J. Harel, R. Higgins, M. Gottschalk, and M. Bigras-Poulin, “Genomic relatedness among reference strains of different Streptococcus suis serotypes,” Canadian J. of Veterinary Research, Vol.58, pp. 259-262, 1994.
  53. [53] O. Okwumabua, J. Staats, and M. M. Chengappa, “Detection of genomicheterogeneity in Streptococcus suis isolates by DNA restriction fragment length polymorphisms of rRNA genes (ribotyping),” J. of Clinical Microbiology, Vol.33, pp. 968-972, 1995.
  54. [54] S. Chatellier, J. Harel, Y. Zhang, M. Gottschalk, R. Higgins, L. A. Devriese, and R. Brousseau, “Phylogenetic diversity of Streptococcus suis strains of various serotypes as revealed by 16S rRNA gene sequence comparison,” Int. J. of Systematic Bacteriology, Vol.48, pp. 581-589, 1998.
  55. [55] T. Sekizaki, Y. Otani, M. Osaki, D. Takamatsu, and Y. Shimoji, “Evidence for horizontal transfer of SsuDAT1I restrictionmodification genes to the Streptococcus suis genome,” J. of Bacteriology, Vol.183, pp. 500-511, 2001.
  56. [56] T. Sekizaki, M. Osaki, D. Takamatsu, and Y. Shimoji, “Distribution of the SsuDAT1I restriction-modification system among different serotypes of Streptococcus suis,” J. of Bacteriology, Vol.183, pp. 5436-5440, 2001.
  57. [57] D. Takamatsu, M. Osaki, and T. Sekizaki, “Evidence for lateral transfer of the suilysin gene region of Streptococcus suis,” J. of Bacteriology, Vol.184, pp. 2050-2057, 2002.
  58. [58] I. Feder, M. M. Chengappa, B. Fenwick, M. Rider, and J. Staats, “Partial characterization of Streptococcus suis type 2 hemolysin,” J. of Clinical Microbiology, Vo.32, pp. 1256-1260, 1994.
  59. [59] T. Sekizaki, D. Takamatsu, M. Osaki, and Y. Shimoji, “Different foreign genes incidentally integrated into the same locus of the Streptococcus suis genome,” J. of Bacteriology, Vol.187, pp. 872-883, 2005.
  60. [60] R. K. Selander, D. A. Caugant, H. Ochman, J. M. Musser, M. N. Gilmour, and T. S. Whittam, “Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematic,” Applied and Environmental Microbiology, Vol.51, pp. 873-884, 1986.
  61. [61] S. J. King, J. A. Leigh, P. J. Heath, I. Luque, C. Tarradas, C. G. Dowson, and A. M. Whatmore, “Development of a multilocus sequence typing scheme for the pig pathogen Streptococcus suis: identification of virulent clones and potential capsular serotype exchange,” J. of Clinical Microbiology, Vol.40, pp. 3671-3680, 2002.
  62. [62] C. Ye, X. Zhu, H. Jing, H. Du, M. Segura, H. Zheng, B. Kan, L. Wang, X. Bai, Y. Zhou, Z. Cui, S. Zhang, D. Jin, N. Sun, X. Luo, J. Zhang, Z. Gong, X. Wang, L. Wang, H. Sun, Z. Li, Q. Sun, H. Liu, B. Dong, C. Ke, H. Yuan, H. Wang, K. Tian, Y. Wang, M. Gottschalk, and J. Xu, “Streptococcus suis sequence type 7 outbreak, Sichuan, China,” Emerging Infectious Diseases, Vol.12, pp. 1203-1208, 2006.
  63. [63] A. Kerdsin, S. Dejsirilert, P. Puangpatra, S. Sripakdee, K. Chumla, N. Boonkerd, P. Polwichai, S. Tanimura, D. Takeuchi, T. Nakayama, S. Nakamura, Y. Akeda, M. Gottschalk, P. Sawanpanyalert, and K. Oishi, “Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand,” Emerging Infectious Diseases, Vol.17, pp. 835-842, 2011.
  64. [64] S. K. Mazmanian, G. Liu, H. Ton-That, and O. Schneewind, “Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall,” Science, Vol.285, pp. 760-763, 1999.
  65. [65] O. Schneewind, D. Mihaylova-Petkov, and P. Model, “Cell wall sorting signals in surface proteins of Gram-positive bacteria,” EMBO Journal, Vol.12, pp. 4803-4811, 1993.
  66. [66] H. Ton-That, G. Liu, S. K. Mazmanian, K. F. Faull, and O. Schneewind, “Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif,” Proc. of the National Academy of Sciences USA, Vol.96, pp. 12424-12429, 1999.
  67. [67] H. Ton-That, S. K. Mazmanian, K. F. Faull, and O. Schneewind, “Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase-catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH2-Gly3 substrates,” J. of Biological Chemistry, Vol.275, pp. 9876-9881, 2000.
  68. [68] M. J. Pallen, A. C. Lam, M. Antonio, and K. Dunbar, “An embarrassment of sortases – a richness of substrates?,” Trends in Microbiology, Vol.9, pp. 97-101, 2001.
  69. [69] M. Osaki, D. Takamatsu, Y. Shimoji, and T. Sekizaki “Characterization of Streptococcus suis genes encoding proteins homologous to sortase of gram-positive bacteria, J. of Bacteriology,” Vol.184, pp.971-982, 2002.
  70. [70] M. Osaki, D. Takamatsu, Y. Shimoji, and T. Sekizaki, “Allelic variation in srtAs of Streptococcus suis strains,” FEMS Microbiology Letters, Vol.219, pp. 195-201, 2003.
  71. [71] G. Vanier, T. Sekizaki, M. C. Domínguez-Punaro, M. Esgleas, M. Osaki, D. Takamatsu, M. Segura, and M. Gottschalk, “Disruption of srtA gene in Streptococcus suis results in decreased interactions with endothelial cells and extracellular matrix proteins,” Veterinary Microbiology, Vol.127, pp. 417-424, 2008.
  72. [72] S. Dramsi, P. Trieu-Cuot, and H. Bierne, “Sorting sortases: a nomenclature proposal for the various sortases of Gram-positive bacteria,” Research in Microbiology, Vol.156, pp. 289-297, 2005.
  73. [73] H. Ton-That and O. Schneewind, “Assembly of pili in Grampositive bacteria,” Trends in Microbiology, Vol.12, pp. 228-234, 2004.
  74. [74] J. R. Scott and D. Zähner, “Pili with strong attachments: Grampositive bacteria do it differently,” Molecular Microbiology, Vol.62, pp. 320-330, 2006.
  75. [75] J. L. Telford, M. A. Barocchi, I. Margarit, R. Rappuoli, and G. Grandi, “Pili in Gram-positive pathogens,” Nature Reviews Microbiology, Vol.4, pp. 509-519, 2006.
  76. [76] A. Mandlik, A. Das, and H. Ton-That, “The molecular switch that activates the cell wall anchoring step of pilus assembly in grampositive bacteria,” Proc. of the National Academy of Sciences USA, Vol.105, pp. 14147-14152, 2008.
  77. [77] N. Fittipaldi, M. Gottschalk, G. Vanier, F. Daigle, and J. Harel, “Use of selective capture of transcribed sequences to identify genes preferentially expressed by Streptococcus suis upon interaction with porcine brain microvascular endothelial cells,” Applied and Environmental Microbiology, Vol.73, pp. 4359-4364, 2007.
  78. [78] D. Takamatsu, H. Nishino, T. Ishiji, J. Ishii, M. Osaki, N. Fittipaldi, M. Gottschalk, P. Tharavichitkul, S. Takai, and T. Sekizaki, “Genetic organization and preferential distribution of putative pilus gene clusters in Streptococcus suis,” Veterinary Microbiology, Vol.138, pp. 132-139, 2009.
  79. [79] N. Fittipaldi, J. Xu, S. Lacouture, P. Tharavichitkul, M. Osaki, T. Sekizaki, D. Takamatsu, and M. Gottschalk, “Two lineages of different virulence predominate among North American isolates of Streptococcus suis serotype 2,” Emerging Infectious Diseases, Vol.17, pp. 2239-2244, 2011.
  80. [80] N. Fittipaldi, D. Takamatsu, M. Doínguez-Punaro, M. Lecours, D. Montpetit, M. Osaki, T. Sekizaki, and M. Gottschalk, “Mutations in the gene encoding the ancillary pilin subunit of the Streptococcus suis srtF cluster result in pili formed by the major pilin subunit only,” PLoS ONE, Vol.5, pp. e8426, 2010.
  81. [81] M. Okura, M. Osaki, N. Fittipaldi, M. Gottschalk, T. Sekizaki, and D. Takamatsu, “The minor pilin subunit Sgp2 is necessary for assembly of the pilus encoded by the srtG cluster of Streptococcus suis,” J. of Bacteriology, Vol.193, pp. 822-831, 2011.
  82. [82] N. Charland, J. Harel, M. Kobisch, S. Lacasse, and M. Gottschalk, “Streptococcus suis serotype 2 mutants deficient in capsular expression,” Microbiology, Vol.144, pp. 325-332, 1998.
  83. [83] H. E. Smith, M. Damman, J. van der Velde, F.Wagenaar, H. J.Wisselink, N. Stockhofe-Zurwieden, and M. A. Smits, “Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor,” Infection and Immunity, Vol.67, pp. 1750-1756, 1999.
  84. [84] G. Chabot-Roy, P. Willson, M. Segura, S. Lacouture, and M. Gottschalk, “Phagocytosis and killing of Streptococcus suis by porcine neutrophils,” Microbial Pathogenesis Vol.41, pp. 21-32, 2006.
  85. [85] L. Benga, M. Fulde, C. Neis, R. Goethe, and P. Valentin-Weigand, “Polysaccharide capsule and suilysin contribute to extracellular survival of Streptococcus suis co-cultivated with primary porcine phagocytes,” Veterinary Microbiology Vol.132, pp. 211-219, 2008.
  86. [86] N. Lakkitjaroen, D. Takamatsu, M. Okura, M. Sato, M. Osaki, and T. Sekizaki, “Loss of Capsule among Streptococcus suis Isolates from Porcine Endocarditis and its Biological Significance,” J. of Medical Microbiology, Vol.60, pp. 1669-1676, 2011.
  87. [87] P. M. Sullam, A. S. Bayer, W. M. Foss, and A. L. Cheung, “Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis,” Infection and Immunity, Vol.64, pp. 4915-4921, 1996.
  88. [88] S. I. Salasia, C. Lammler, and G. Herrmann, “Properties of a Streptococcus suis isolate of serotype 2 and two capsular mutants,” Veterinary Microbiology, Vol.45, pp. 151-156, 1995.
  89. [89] L. Benga, R. Goethe, M. Rohde, and P. Valentin-Weigand, “Nonencapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells,” Cellular Microbiology, Vol.6, pp. 867-881, 2004.
  90. [90] L. Benga, , P. Friedl, and P. Valentin-Weigand, “Adherence of Streptococcus suis to porcine endothelial cells,” J. of Veterinary Medicine B Infectious Disease and Veterinary Public Health, Vol.52, pp. 392-395, 2005.
  91. [91] M. Esgleas, S. Lacouture, and M. Gottschalk, “Streptococcus suis serotype 2 binding to extracellular matrix proteins,” FEMS Microbiology Letters, Vol.244, pp. 33-40, 2005.
  92. [92] S. Tanabe, L. Bonifait, N. Fittipaldi, L. Grignon, M. Gottschalk, and D. Grenier, “Pleiotropic effects of polysaccharide capsule loss on selected biological properties of Streptococcus suis,” Canadian J. of Veterinary Research, Vol.73, pp. 65-70, 2009.

*This site is desgined based on HTML5 and CSS3 for modern browsers, e.g. Chrome, Firefox, Safari, Edge, Opera.

Last updated on Oct. 21, 2021